Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 80

1.

Continuous infusion of rFVIIa during surgery in a FVII-deficient patient: a case report from Japan.

Nagao A, Hanabusa H, Takedani H.

Haemophilia. 2014 Jan;20(1):e110-2. doi: 10.1111/hae.12328. No abstract available.

PMID:
24354483
2.

Total hip arthroplasty in severe congenital factor VII deficiency: successful use of recombinant activated factor VII for hemostasis.

Niikura T, Nishikawa T, Saegusa Y, Fujishiro T, Yoshiya S, Kurosaka M.

J Arthroplasty. 2005 Apr;20(3):396-400.

PMID:
15809961
3.

Continuous infusion of recombinant factor VIIa for surgery in patients with deficiency of factor VII.

Schulman S, Tjønnfjord GE, Wallensten R, Martinowitz U, Kenet G.

Thromb Haemost. 2005 Dec;94(6):1177-80.

PMID:
16411390
4.

Management of factor VII-deficient patients undergoing joint surgeries--preliminary results of locally developed treatment regimen.

Windyga J, Zbikowski P, Ambroziak P, Baran B, Kotela I, Stefanska-Windyga E.

Haemophilia. 2013 Jan;19(1):89-93. doi: 10.1111/j.1365-2516.2012.02921.x. Epub 2012 Jul 30.

PMID:
22845882
5.

Successful prophylactic use of recombinant activated factor VII (rFVIIa) in a patient with congenital FVII deficiency and inhibitors to FVII.

Tokgoz H, Caliskan U, Lavigne-Lissalde G, Giansily-Blaizot M.

Haemophilia. 2012 Jan;18(1):e25-7. doi: 10.1111/j.1365-2516.2011.02666.x. Epub 2011 Oct 4. No abstract available.

PMID:
21973016
6.

Prophylaxis with recombinant-activated factor VII (rFVIIa) for minimally invasive surgery in a patient with congenital factor VII deficiency: a case report with a single-low dose of rFVIIa.

Yilmaz AA, Yalcin S, Serdaroglu H, Sonmezer M, Uysalel A.

Blood Coagul Fibrinolysis. 2008 Oct;19(7):693-5. doi: 10.1097/MBC.0b013e3282f544ff.

PMID:
18832912
7.

Continuous infusion of recombinant activated factor VII for bleeding control after lobectomy in a patient with inherited factor VII deficiency.

Miyata N, Isaka M, Kojima H, Maniwa T, Takahashi S, Takamiya O, Ohde Y.

Gen Thorac Cardiovasc Surg. 2016 Mar;64(3):177-80. doi: 10.1007/s11748-014-0455-1. Epub 2014 Jul 24.

PMID:
25056454
8.

Triple coronary artery bypass graft surgery in a patient with factor VII deficiency: a case report.

Frattini F, Bonfanti C, Piccoli P, Camurri N, Mantovani P, Terenziani I, Caramaschi G, Rambaldini M, Manzato F, Franchini M.

Haemophilia. 2013 Jul;19(4):e268-9. doi: 10.1111/hae.12164. Epub 2013 May 7. No abstract available.

PMID:
23647837
9.

rFVIIa administered by continuous infusion during surgery in patients with severe congenital FVII deficiency.

Tran HT, Tjønnfjord GE, Paus A, Holme PA.

Haemophilia. 2011 Sep;17(5):764-70. doi: 10.1111/j.1365-2516.2011.02596.x. Epub 2011 Jun 26.

PMID:
21707871
10.

Successful coronary artery bypass grafting in a patient with severe FVII deficiency and minimal use of recombinant FVIIa.

Martin K, McMahon B.

Haemophilia. 2014 Jan;20(1):e94-7. doi: 10.1111/hae.12307. Epub 2013 Nov 22. Review. No abstract available.

PMID:
24261666
11.
12.

Prevention of bleeding and hemorrhagic complications in surgical patients with inherited factor VII deficiency.

Wiszniewski A, Szczepanik A, Misiak A, Bykowska K, Szopiński P.

Blood Coagul Fibrinolysis. 2015 Apr;26(3):324-30. doi: 10.1097/MBC.0000000000000258.

PMID:
25688458
13.

Recombinant factor VIIa prophylaxis in a patient with severe congenital factor VII deficiency.

Tcheng WY, Donkin J, Konzal S, Wong WY.

Haemophilia. 2004 May;10(3):295-8.

PMID:
15086331
14.

Management of Labour and Delivery in a Patient With Acquired Factor VII Deficiency With Inhibitor: A Case Report.

Matei A, Dolan S, Andrews J, Rivard GÉ.

J Obstet Gynaecol Can. 2016 Feb;38(2):160-3. doi: 10.1016/j.jogc.2015.11.002. Epub 2016 Mar 2.

PMID:
27032741
15.
16.

Use of recombinant, activated factor VII in the treatment of congenital factor VII deficiencies.

Mariani G, Testa MG, Di Paolantonio T, Molskov Bech R, Hedner U.

Vox Sang. 1999;77(3):131-6.

PMID:
10545848
17.

Concurrent total hip and knee replacements in a patient with haemophilia with inhibitors using recombinant factor VIIa by continuous infusion.

Tagariello G, Bisson R, Radossi P, Petris U, Zanardo G, De Biasi E, Risato R, Polese F, Davoli PG.

Haemophilia. 2003 Nov;9(6):738-40.

PMID:
14750941
18.

A rare combination: congenital factor VII deficiency with Chiari malformation.

Bay A, Aktekin E, Erkutlu I.

Blood Coagul Fibrinolysis. 2015 Dec;26(8):946-8. doi: 10.1097/MBC.0000000000000322.

PMID:
26248161
19.

A comparison between recombinant activated factor VII (Aryoseven) and Novoseven in patients with congenital factor VII deficiency.

Faranoush M, Abolghasemi H, Toogeh G, Karimi M, Eshghi P, Managhchi M, Hoorfar H, Dehdezi BK, Mehrvar A, Khoeiny B, Kamyar K, Heshmat R, Baghaeipour MR, Mirbehbahani NB, Fayazfar R, Ahmadinejad M, Naderi M.

Clin Appl Thromb Hemost. 2015 Nov;21(8):724-8. doi: 10.1177/1076029614522545. Epub 2014 Mar 19.

PMID:
24651301
20.

Pharmacokinetic evaluation of recombinant, activated factor VII in patients with inherited factor VII deficiency.

Berrettini M, Mariani G, Schiavoni M, Rocino A, Di Paolantonio T, Longo G, Morfini M.

Haematologica. 2001 Jun;86(6):640-5.

Supplemental Content

Support Center